Active ingredient
Nilotinib
25 finished FDA listings contain Nilotinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- NILOTINIB, NILOTINIB HYDROCHLORIDE MONOHYDRATE, NILOTINIB TARTRATE
- Dosage forms
- Capsule, Tablet, Tablet, Orally Disintegrating
- Routes
- Oral
- Manufacturers / labelers
- 10
- Strengths listed
- 150 mg/1 · 200 mg/1 · 50 mg/1 · 60 mg/1 · 71 mg/1 · 80 mg/1 · 95 mg/1
- Brand names in FDA listings
- Cavhanza, Danziten, Tasigna
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 662281
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022068 | NOVARTIS | 2007-10-29 | 3 |
| ANDA 203640 | APOTEX | 2024-01-05 | 3 |
| NDA 219293 | AZURITY | 2024-11-07 | 2 |
| NDA 218922 | CIPLA | 2025-02-19 | 3 |
| ANDA 218544 | MSN | 2025-11-19 | 5 |
| ANDA 209651 | HETERO LABS LTD V | 2025-11-19 | 2 |
| ANDA 218350 | DR REDDYS | 2025-11-19 | 3 |
| ANDA 218532 | TORRENT | 2025-12-15 | 2 |
| NDA 217379 | CYCLE | 2026-05-29 | 2 |
Official labeling on DailyMed
- NILOTINIB CAPSULE [TORRENT PHARMACEUTICALS LIMITED] · version 6 · 2026-09-02
- CAVHANZA (NILOTINIB) TABLET, ORALLY DISINTEGRATING [CYCLE PHARMACEUTICALS LTD] · version 4 · 2026-08-13
- NILOTINIB CAPSULE [APOTEX CORP.] · version 10 · 2026-06-10
- NILOTINIB CAPSULE [AVKARE] · version 1 · 2026-03-03
- TASIGNA (NILOTINIB) CAPSULE [NOVARTIS PHARMACEUTICALS CORPORATION] · version 42 · 2025-12-18
- NILOTINIB CAPSULE [NOVADOZ PHARMACEUTICALS LLC] · version 1 · 2025-11-21
- NILOTINIB (NILOTINIB) CAPSULE [CAMBER PHARMACEUTICALS, INC.] · version 3 · 2025-11-21
- NILOTINIB (NILOTINIB) CAPSULE [DR. REDDY'S LABORATORIES INC] · version 9 · 2025-11-20
- NILOTINIB CAPSULE [CIPLA USA INC.] · version 5 · 2025-11-18
- DANZITEN (NILOTINIB) TABLET [AZURITY PHARMACEUTICALS, INC.] · version 3 · 2025-07-31
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.